1Okamoto H,Shoin S,Koshimura S.Streptolysin S.forming and antitumor activities of group A streptococi.Academic Press,in "Bocterial toxin and cell membranes"[M].Jeljaszewicz J,Wadsfrom T,eds.Lodon:Academic Press,1978:259-289.
2Okamoto M,Oshikawa T,Tano T,et al.Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432[J].J Natl Cancer Inst,2003,95 (4):316-326.
3Tatsugami K,Tamada K,Abe K,et al.Local injections of OK-432 can help the infiltration of adoptively transferred CD8^+ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines[J].Cancer Immunol Immunother,2000,49(7):361-368.
4Yano T,Ichinose Y,Yokoyama H,et al.Inhalation therapy using a streptococcal preparation (OK-432) against bronchioloalveolar carcinoma of the lung[J].Anticancer Res,1999,19(6C):5511-5514.
5Okamoto M,Gohda H,Ohe G,et al.Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432,a streptococcal preparation[J].J Immunother,2000,23(1):94-103.
6Okamoto M,Ohe G,Oshikawa T,et al.Enhancement of anticancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus[J].Cancer Immunol Immunother,2001,50 (8):408-416.
7Kawano T,Cui J,Koezuka Y,et al.CDld-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides[J].Science,1997,278(5343):1626-1629.
8Beckman E M,Porcelli S A,Morita C T,et al.Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells[J].Nature,1994,372(6507):691-694.
9Okamoto M,Ohe G,Oshikawa T,et al.Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432,a penicillin-killed streptococcal agent[J].Immunopharmacology,2000,49 (3):363-376.
10Ryoma Y,Moriya Y,Okamoto M,et al.Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy[J].Anticancer Res,2004,24 (5):3295-3301.
